Joern Klinger ^UDM

Joern Klinger is the Founder and CEO of biotx.ai, where he draws on his experience from Traq21 to lead the development of an ecosystem for measuring brand attractiveness through social media and web user behavior. At Traq21, Joern created and maintained this ecosystem, handling data analysis on the technical side and aligning it with business demands and third-party collaborations on the operational side. In his current role, he spearheads the use of machine learning and AI in biomarker development and drug discovery at biotx.ai, a company dedicated to delivering predictive biomarkers for decision support in precision medicine. The company employs state-of-the-art machine learning approaches designed to uncover complex patterns in biomedical data.